KOSDAQ large-cap bio with earnings Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
03:10
Jan 02
Jan 02
Korean bio benefits from policy, politics.
The US political backdrop with weak Trump approval favors anti-Republican sectors such as healthcare. In Korea, KOSDAQ support policy matters because KOSDAQ market cap is heavily bio, and the government wants to support large-cap KOSDAQ bio names with earnings rather than small speculative biotech.
MED
About KOSDAQ large-cap bio with earnings Investor Commentary
Across the available history and selected sources, Buzzberg tracks KOSDAQ large-cap bio with earnings across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lee Hyuk-jin.